Marcus W. Brazier - Concepedia

Author

Marcus W. Brazier

The University of Melbourne

Also Known As

M. Brazier, Marcus Brazier, Marcus W Brazier, Marcus W. Brazier, Marcus W. Brazier

Publications

847

Citations

H-Index

Concepts

All Affiliations

The University of Melbourne Mental Health Research Institute University of Bath Queen Mary University of London Heidelberg University

About

Marcus W. Brazier is an author at The University of Melbourne specializing in medicine, proteomics, and natural sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	547
2	Natural Sciences	8	8	419
3	Biochemistry	7	7	400
4	Cell Biology	2	2	56
5	Allergy	1	1	19

Marcus W. Brazier

Publications

761

Citations

H-Index

Page 1

	Year	Citations
Quinacrine does not prolong survival in a murine Creutzfeldt‐Jakob disease model Steven Collins, Victoria Lewis, Marcus W. Brazier, Annals of Neurology	2002	149
Manganese Binding to the Prion Protein Marcus W. Brazier, Paul Davies, Esmie Player, Journal of Biological Chemistry Manganese BindingBiochemistryProtein FoldingMedicineNatural Sciences	2008	97
Prion protein does not redox-silence Cu2+, but is a sacrificial quencher of hydroxyl radicals Rebecca C. Nadal, Salama R. Abdelraheim, Marcus W. Brazier, Free Radical Biology and Medicine BiochemistryProtein FoldingMedicineSacrificial QuencherNatural Sciences	2006	75
Correlative studies support lipid peroxidation is linked to PrPres propagation as an early primary pathogenic event in prion disease Marcus W. Brazier, Victoria Lewis, Giuseppe D. Ciccotosto, Brain Research Bulletin Prpres PropagationCreutzfeldt-jakob DiseaseBiochemistryMedicineNatural Sciences	2005	75
Sublethal Concentrations of Prion Peptide PrP106–126 or the Amyloid Beta Peptide of Alzheimer's Disease Activates Expression of Proapoptotic Markers in Primary Cortical Neurons Anthony R. White, Marcus W. Brazier, Michael F. Jobling, Neurobiology of Disease Neurodegenerative DiseasesAlzheimer's DiseaseSynaptic TransmissionPrion Peptide Prp106–126Prion Disease	2001	71
A manganese-superoxide dismutase/catalase mimetic extends survival in a mouse model of human prion disease Marcus W. Brazier, Susan R. Doctrow, Colin L. Masters, Free Radical Biology and Medicine BiochemistryMedicineGeneticsNatural SciencesMetalloprotein	2008	55
NMR characterization of the pH 4 β-intermediate of the prion protein: the N-terminal half of the protein remains unstructured and retains a high degree of flexibility Denis O’Sullivan, Christopher E. Jones, Salama R. Abdelraheim, Biochemical Journal Dispersed Amide SignalsPh 4Protein AssemblyBiochemistryProtein Folding	2006	38
Manganese chelation therapy extends survival in a mouse model of M1000 prion disease Marcus W. Brazier, Irene Volitakis, Magda Kvasnicka, Journal of Neurochemistry Brain MnImmunologyReduced Brain PrpOxidative StressExperimental Neuropathology	2010	37
Mouse galectin‐1 inhibits the toxicity of glutamate by modifying NR1 NMDA receptor expression Tamuna Lekishvili, Shirley Hesketh, Marcus W. Brazier, European Journal of Neuroscience	2006	33
Dynamics of a truncated prion protein, PrP(113–231), from <sup>15</sup>N NMR relaxation: Order parameters calculated and slow conformational fluctuations localized to a distinct region Denis O’Sullivan, Christopher E. Jones, Salama R. Abdelraheim, Protein Science	2009	32

Page 1